Cable Hill Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cable Hill Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-51	Closed	-$6K	–	793
2019 Q1	$6K	Hold	51	–	–	﹤0.01%	588
2018 Q4	$5K	Hold	51	–	–	﹤0.01%	582
2018 Q3	$5K	Sell	51 -9	-15%	-$937	﹤0.01%	593
2018 Q2	$6K	Hold	60	–	–	﹤0.01%	632
2018 Q1	$5K	Sell	60 -94	-61%	-$8.35K	﹤0.01%	689
2017 Q4	$14K	Hold	154	–	–	0.01%	502
2017 Q3	$12K	Sell	154 -3	-2%	-$227	0.01%	539
2017 Q2	$12K	Sell	157 -1	-0.6%	-$69	0.01%	376
2017 Q1	$10K	Sell	158 -3	-2%	-$177	0.01%	403
2016 Q4	$9K	Hold	161	–	–	﹤0.01%	432
2016 Q3	$9K	Sell	161 -16	-9%	-$785	0.01%	457
2016 Q2	$8K	Hold	177	–	–	0.01%	419
2016 Q1	$8K	Buy	177 +2	+1%	+$85	0.01%	397
2015 Q4	$8K	Hold	175	–	–	0.01%	400
2015 Q3	$7K	Buy	+175	New	+$7.01K	0.01%	442

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Cable Hill Partners's PRAH Position: Q2 2019 in Review

Cable Hill Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 51 shares — an estimated $6K sold.

Cable Hill Partners first reported a position in PRAH in Q3 2015 and held it in 15 quarters. The position peaked at $14K in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

Cable Hill Partners reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 51 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $6K.
Cable Hill Partners first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 15 quarters.
Cable Hill Partners's PRA Health Sciences, Inc. position peaked at $14K in Q4 2017.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.